OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX

Rhea-AI Summary

OTC Markets Group (OTCQX: OTCM) announced that Enzo Biochem (OTCQX: ENZB), a life sciences company, has qualified to trade on the OTCQX® Best Market after transitioning from the New York Stock Exchange. Trading commenced under the symbol 'ENZB' on April 21, 2025.

The OTCQX Market provides companies with cost-effective access to U.S. capital markets through streamlined requirements while maintaining transparency for investors. Companies must meet high financial standards, follow best practice corporate governance, and demonstrate securities law compliance to qualify.

CEO Kara Cannon expressed satisfaction with the transition, highlighting OTCQX's platform for investor engagement while maintaining their focus on life science products and services.

Positive

• Cost reduction through streamlined market requirements
• Maintained access to U.S. capital markets with transparent trading

Negative

• Downgrade from NYSE listing to OTCQX market may indicate reduced market presence

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Enzo Biochem, Inc. (OTCQX: ENZB), life sciences company, has qualified to trade on the OTCQX^® Best Market. Enzo Biochem, Inc. previously traded on the New York Stock Exchange.

Enzo Biochem, Inc. begins trading today on OTCQX under the symbol “ENZB.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

Trading on the OTCQX Market offers companies efficient, cost-effective access to the U.S. capital markets. Streamlined market requirements for OTCQX are designed to help companies lower the cost and complexity of being publicly traded, while providing transparent trading for their investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.

“Enzo Biochem, Inc. is pleased to begin trading on the OTCQX, which provides an excellent platform for investors to engage with the company as we continue to provide exceptional life science products and services,” said Kara Cannon, CEO of Enzo Biochem, Inc.

About Enzo Biochem, Inc.
Enzo Biochem, Inc. has operated as a life sciences company for over 45 years. The primary business of Enzo today is conducted through its Life Sciences division, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The Company monetizes its technology primarily via sales through our global distribution network and licensing. Enzo Life Sciences is operated through the Company’s wholly-owned subsidiary Enzo Life Sciences, Inc. and its wholly-owned foreign subsidiaries.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX^® Best Market, OTCQB^® Venture Market and Pink^® Open Market.

Our OTC Link^® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.

OTC Link ATS, OTC Link ECN, OTC Link NQB, and MOON ATS^TM are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

Subscribe to the OTC Markets RSS Feed

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com

FAQ

Why did Enzo Biochem (ENZB) move from NYSE to OTCQX in April 2025?

Enzo Biochem transitioned to OTCQX for more cost-effective access to U.S. capital markets while maintaining transparent trading for investors through streamlined market requirements.

What are the requirements for trading on OTCQX Best Market?

Companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.

When did Enzo Biochem (ENZB) begin trading on OTCQX?

Enzo Biochem began trading on the OTCQX Best Market on April 21, 2025, under the symbol ENZB.

How many securities does OTC Markets Group (OTCM) operate markets for?

OTC Markets Group operates regulated markets for trading 12,000 U.S. and international securities.